Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Belated Introduction to Dr. Charu Aggarwal
Author
Howard (Jack) West, MD

Many of you already participating on the lung cancer section of the GRACE site have seen the first few responses by Dr. Aggarwal, though they have preceded my proper introduction of her.  Apologies -- we had talked a few months ago about having her start sometime around now, though I hadn't anticipated her laudable enthusiasm and courage to jump right in.  So let me now provide a little background.  

Dr. Charu Aggarwal is an Assistant Professor in the Hematology/Oncology Division at the University of Pennsylvania, where she has a particular focus on lung cancer.  She started her medical training at the Lady Hardinge Medical College in New Delhi, then came to the US and did a Master’s in Public Health at the University of Alabama, Birmingham.  She then did her internship and residency training in internal medicine at the State University of New York, Buffalo before moving to Philadelphia to do her medical oncology fellowship training at the Fox Chase Cancer Center.   Last year she moved to the University of Pennsylvania to join their faculty.  

 

Our friend Dr. Weiss here has known Dr. Aggarwal from his time in Philadelphia, as he had trained at the University of Pennsylvania and knew Dr. Aggarwal from the cancer scene in Philadelphia (I guess if you consider there to be such a thing).  He had recommended here, and I've had the chance to spend some time talking with and trying to recruit her to work with us.  Her background includes an impressive collection of awards for academic achievements, her research efforts, and bedside manner -- I think this is a great combination that I hope will lead to her becoming a recurring, always welcomed addition to the GRACE faculty.

 

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on